Anthropic says Claude autonomously discovered a new enzyme system in the DNA of bacteriophages, somewhat similar to CRISPR, the first result from its new biolab
It took nearly 1,000 Claude agents 21 hours and 210 million tokens to uncover the ‘novel enzyme system.’
The VergeRobert Hart
Context & Ripple Effects
Anthropic had already built a multi-agent research system, tested Claude against bioinformatics experts, and launched Claude Science with scientific databases and specialist toolkits. Its earlier protein-design and chemical-analysis experiments framed Claude as an accelerator; the biolab result extends that arc to an agent-led search that surfaced a candidate biological system whose role is not yet known.
First-order effects
Anthropic gains a concrete first output for its molecular-biology lab, linking Claude's agent orchestration to a potential research finding rather than only workflow and benchmark claims.
The reported enzyme system becomes a validation target for Anthropic's biologists; its CRISPR-like repeat structure does not establish a gene-editing function.
Second-order effects
Researchers assessing Anthropic's science products have a clearer reason to evaluate the full agent-plus-database workflow, while the reported 210 million-token run makes inference use part of that evaluation.
Anthropic can position Claude Life Sciences and Claude Science as connected layers—from lab-tool integration and data access to autonomous research planning and analysis.
Third-order effects
If candidate findings from agent runs are repeatedly validated in the lab, scientific-AI competition will shift from answer quality alone toward reproducible discovery pipelines with clear human verification steps.
The economics of large-scale agent searches will become a product constraint: research platforms will need to show that costly parallel inference produces findings worth experimental follow-up.
The trend: Scientific AI is moving from assisting individual analyses toward orchestrating multi-agent searches that generate experimentally testable biological hypotheses.
Claude has discovered a previously unknown enzyme system hidden in the DNA of bacteriophages. Beside the enzyme's gene sits a long array of repeating DNA—a structure that looks somewhat similar to CRISPR. We don't yet understand what this system does, but only a handful of known …
This is the first result from our new molecular biology lab, where a team of Anthropic biologists is using Claude to explore and accelerate fundamental biology research. There, Claude works through data and literature to generate hypotheses and candidate biological systems to stu…
77 agent-hours over 21.5 hours of wall-clock time, so roughly ~4 parallel agents working at once? isn't that... low? (navier-stokes was supposedly 88 hours of wall-clock time, ~10k agents) tech report also does not mention anything about what has been tested in the wet lab (inten…
the coolest thing about a new technological revolution like ai is that it forces you to rethink nearly every assumption about how the world used to work (kinda like how elon approaches every big problem). e.g. at one layer personal agents are trying to reshape how ppl manage thei…
At @ginkgo we've been experiencing that to keep autonomous labs busy you need agents planning experiments and interpreting data — so I really like this approach from @anthropic in general. Autonomous labs need AI and AI needs autonomous labs to do science (at scale).
Discoveries like CRISPR, Taq polymerase (PCR), and restriction enzymes all came from looking closely at things that already exist in nature and finding useful tools. These kinds of discoveries, ones that reshape entire fields, come along only once in a while. We set up a research…
Today we announced the Claude-led discovery of a molecular machine that we suspect could represent a new gene editing mechanism. Its precise function, biotechnological utility (if any), or level of significance is not yet clear, but at minimum it is work I would have been proud t…
We've set up a molecular biology lab at Anthropic and we're announcing our first discovery! Claude discovered a new CRISPR-like enzyme. 950 agents spent 21 hours searching through a database of DNA sequences until one of the agents found something striking:
Thrilled to share news of our team and the research we're doing at Anthropic! Over the last year, the advance of Claude's capabilities in biology has been breathtaking. As “traditional
Dario Amodei still believes AI could “cure most diseases in 5-10 years,” and Anthropic's latest discovery offers an early glimpse of the research he thinks could get us there. He calls that goal “barely possible
it's cool that Claude found something that looks like it might be CRISPR-like. but let's not go *too* crazy. from the pop science press I'm aware of at least two post-CRISPR systems of this type that humans have found (Vipr, Fanzor). The NYT has written about this!
this is absolutely incredible we are watching AI begin to discover entirely new biological systems that humans didn't even know existed. AI is actually expanding the frontier of biology itself. once again, this is the age of biotech.
The sad thing is that Dario knows better. He was a PhD student. He knows the significance level of this result. He knows that if he had walked into Bill's office (his advisor) with “we found an interesting system, but we still don't know what it does” and said he was ready to …
Anthropic has a wet lab in SF where they're using Claude to accelerate fundamental biology research — This is the first big result from that lab — discovery of a CRISPR-like enzyme — www.anthropic.com/news/claude- ...
As someone who did this kind of genome mining work during my PhD, some thoughts on this Anthropic announcement: First, the very simplified version of what they did is that they noticed two genes (one known, one new) sitting next to a weird repeating piece of DNA. More specificall…